The first head-to-head randomized controlled trial comparing new intermediate-sized valves to contemporary standards shows the new approach enables precise matching of devices.
Germany: In-stent neoatherosclerosis (NA) is frequently seen after endovascular therapy in lower limb arteries through OCT imaging; this increased both in extent and frequency the longer the duration.
Neovasc Inc.: Neovasc Announces Publication of Peer-Reviewed Article in EuroIntervention
REDUCER I Study Shows Improvement in Chest Pain Symptoms
Vancouver, British Columbia and Minneapolis, Minnesota (Newsfile Corp. - December 17, 2020) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ( Neovasc or the Company ) announced today that
EuroIntervention, the official journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI), has published online a peer-reviewed study announcing the outcomes of patients undergoing Neovasc Reducer ( Reducer ) implantation in the Company s REDUCER-I trial. The article, entitled Coronary Sinus Narrowing for the Treatment of Refractory Angina A Multi-center Prospective Open-label Clinical Study (The REDUCER-I Study) , is the latest of numerous publications supporting the safety and effectiveness of the Reducer. The trial examined the safety and efficacy of the coronary sinus (CS) Reducer in improving angina severity and q